Clinical Trials Logo

Clinical Trial Summary

INTRODUCTION: Global protein consumption has been increasing for decades due to changes in socio-economic demographics and consumer trends towards higher protein intake, which may be related to their health benefits in performance nutrition and appetite regulation. The additional intake of protein often occurs in the form of supplements. One of the main ingredients used in sports and weight loss supplements are animal-derived proteins such as whey, which are of high quality, containing all the essential amino acids required in human nutrition with a high absorption rate. However, whey protein has a high environmental footprint, and it may contribute to insulin resistance in susceptible groups (e.g. obese, T2DM, insulin resistant, or those with sarcopenic obesity). Rice and potato protein isolates are high-quality plant proteins containing all essential amino acids comparably to whey protein. These plant-derived proteins may provide a more sustainable and accessible alternative to animal-derived proteins for appetite regulation and weight management.


Clinical Trial Description

Intervention study with three treatment groups in a randomised, single-blind, triple crossover design. Study population: Healthy male participants will receive three different isocaloric and -volumetric protein shakes prepared using whey, rice and potato protein powders on different trial days with at least a one-week washout period apart. Biological samples (blood and saliva samples) are collected at various time points during the visit. Blood samples are collected at baseline 10 min prior (T-10), then at 30 min (T30), 60 min (T60), 120 min (T120) and at 180 min (T180) after protein shake consumption. Saliva samples are collected at baseline (T-10), then at every 30 minutes following protein shake consumption (T30, T60, T90, T120, T150, T180). In addition, pertinent questionnaires Visual Analogue Scale [VAS] for the assessment of satiety and VAS for the assessment of protein shakes' perception will be collected at T-10, T30, T60, T90, T120, T150, T180 and at T0, respectively ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04876495
Study type Interventional
Source University of Westminster
Contact
Status Completed
Phase N/A
Start date July 20, 2018
Completion date February 19, 2021

See also
  Status Clinical Trial Phase
Completed NCT06146322 - Barley Beta-glucan, Glycemic Control, and Appetite N/A
Completed NCT01900340 - Intestinal Glucagon-like Peptide-1 (GLP-1) and the Physiological Role in Eating in Humans Phase 1
Completed NCT02285907 - Protein Quality on Appetite Control, Reward-driven Eating, & Subsequent Food Intake N/A
Completed NCT01354600 - Effects of Positive Energy Balance and Exercise on Appetite Hormones in Sedentary Men and Women N/A
Suspended NCT03031132 - The Effects of a High Protein Breakfast on Appetite and Sleep in Young Adults N/A
Recruiting NCT03009695 - Transcranial Magnetic Stimulation (TMS) in Obesity N/A
Recruiting NCT02075827 - Metabolic Response to Playing Video Games: Two Arm Trial N/A
Withdrawn NCT01946841 - Specific Enteral Nutrition in Malnourished, Dialysis Patients With Chronic Kidney Disease. Efficacy, Safety, Quality of Life Phase 2
Completed NCT01088841 - Sweet Taste Receptors and the Secretion of Glucagon-like Peptide-1 and Peptide YY Phase 1